World's Best Scientists 2026 revealed!
Cellular Oncology
H-index 24

Cellular Oncology

1570-5870

Published by: Springer

https://www.springer.com/journal/13402

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Molecular Biology 125 15 15 8
Biology and Biochemistry 350 67 66 18
Medicine 1568 57 48 16

Additional Metrics

Number of Best Scientists*: 183
Documents by Best Scientists*: 149
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 62
SCIMAGO SJR: 1.573
Impact Factor: 4.8

Overview

Top Research Topics at Cellular Oncology?

The journal aims to foster the development of research in Cancer research, Cancer, Internal medicine, Oncology and Pathology. It explores topics in Cancer research which can be helpful for research in disciplines like Cell culture, Cell growth, Cancer cell, Apoptosis and Metastasis. Many of the studies tackled connect Cell growth with a similar field of study like Gene silencing.

Most of the Cancer studies addressed also intersect with microRNA. The studies tackled, which mainly focus on Internal medicine, apply to Endocrinology as well. The study on Oncology presented in Cellular Oncology intersects with the topics under Carcinoma.

It focuses on Cancer stem cell research as part of the broader topic of Stem cell.

  • Cancer research (52.59%)
  • Cancer (20.98%)
  • Internal medicine (19.82%)

What are the most cited papers published in the journal?

  • HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series. (246 citations)
  • The role of lymphangiogenesis and angiogenesis in tumor metastasis. (152 citations)
  • Rapid quantification of myocardial fibrosis: a new macro-based automated analysis (128 citations)

Research areas of the most cited articles at Cellular Oncology:

The published papers are organized to reinforce research efforts on Cancer research, Cancer, Internal medicine, Oncology and Pathology. While Cancer research is the focus of the published papers, it also provides insights into the studies of Cell growth, Cancer cell, Apoptosis, microRNA and Metastasis. In addition to Cancer research, the most cited publications aim to explore topics under Stromal cell and DNA methylation.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

The journal generally zeroes in on subjects such as Cancer research, Cancer, Cancer cell, Gene knockdown and Tumor microenvironment. The research on Cancer research featured in Cellular Oncology combines topics in other fields like Cell growth, Apoptosis, Downregulation and upregulation, Metastasis and In vivo. Cellular Oncology tackles studies in Angiogenesis and the interrelated subject of Immune system to gain insights into Cancer.

While the journal focused on Cancer cell, it was also able to explore topics like Breast cancer and Signal transduction, Stem cell, Cell biology. In the journal, Estrogen receptor and Cisplatin are investigated in conjunction with one another to address concerns in Gene knockdown research. The tackled Tumor microenvironment research is interrelated with Stromal cell which concerns subjects like Paracrine signalling and Immunotherapy.

The most cited articles from the last journal are:

  • Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. (7 citations)
  • Angiogenesis as a hallmark of solid tumors - clinical perspectives (6 citations)
  • Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cellular Oncology (based on the number of publications) are:

  • Gerrit A. Meijer (32 papers) absent at the last edition,
  • Beatriz Carvalho (19 papers) absent at the last edition,
  • Paul J. van Diest (18 papers) published 1 paper at the last edition,
  • Bauke Ylstra (17 papers) absent at the last edition,
  • Elsken van der Wall (9 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cellular Oncology (based on the number of publications) are:

  • VU University Medical Center (32 papers) absent at the last edition,
  • Utrecht University (29 papers) published 2 papers at the last edition,
  • VU University Amsterdam (21 papers) absent at the last edition,
  • Mashhad University of Medical Sciences (13 papers) absent at the last edition,
  • Leiden University Medical Center (11 papers) published 3 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 0.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.28% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.63% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.28% of all publications and 55.81% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches

    Daniel Cruceriu;Oana Baldasici;Ovidiu Balacescu;Ioana Berindan-Neagoe

    (2020)
    304 Citations
  • Angiogenesis as a hallmark of solid tumors - clinical perspectives

    Jamal Majidpoor;Keywan Mortezaee

    (2021)
    178 Citations
  • CD47: role in the immune system and application to cancer therapy.

    Seyed Mohammad Gheibi Hayat;Vanessa Bianconi;Matteo Pirro;Mahmoud R Jaafari

    (2020)
    160 Citations
  • The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.

    Umar Mehraj;Rais A. Ganai;Muzafar A. Macha;Abid Hamid

    (2021)
    91 Citations
  • Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update

    Pan Xie;Jun-Luan Mo;Jin-Hong Liu;Xi Li

    (2020)
    65 Citations
  • Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance

    Claudio D'Amore;Christian Borgo;Stefania Sarno;Mauro Salvi

    (2020)
    63 Citations
  • How VEGF-A and its splice variants affect breast cancer development – clinical implications

    (2022)
    59 Citations
  • Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy

    (2022)
    59 Citations
  • CXCL-10: a new candidate for melanoma therapy?

    Hossein Bagheri;Mohammad Hossein Pourhanifeh;Maryam Derakhshan;Maryam Mahjoubin-Tehran

    (2020)
    51 Citations

Related Online Degrees & Career Pathways

Exploring related online degrees can be a strategic step for those interested in medicine but looking to diversify their expertise. For example, pursuing one of the best online nutrition programs offers foundational knowledge in dietary science that complements medical training and supports preventive healthcare roles.

Healthcare management is another promising area. Earning a degree through cahme accredited mha programs equips students with skills to efficiently run healthcare organizations, addressing critical operational challenges in hospitals and clinics.

For advanced clinical practice with more flexibility, some may consider online dnp programs without dissertation. These programs emphasize practical skills and leadership without the traditional research requirement, making them accessible for working professionals.

Finally, those interested in leadership roles might explore doctoral programs for healthcare administration, which prepare graduates to influence healthcare policy and management at the highest levels.

Best Scientists Contributing to This Journal

Recently Published Articles